SCHEMBL1052278

SCHEMBL1052278

CCCOc1cccc(O)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
MAPT P10636 3/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 2/20 0.54
ALOX15 P16050 2/20 0.54
HSD17B10 Q99714 2/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
CYP3A4 P08684 1/20 0.54
ALOX12 P18054 1/20 0.54
MAPK1 P28482 1/20 0.54
JAK2 O60674 1/20 0.52
GAA P10253 1/20 0.52
MCHR1 Q99705 1/20 0.45
PTPN1 P18031 1/20 0.44
ADAMTS4 O75173 1/20 0.44
EGFR P00533 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
FYN P06241 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961982 0.91 MCHR1 (0.47) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL67765 0.90 CYP1A2 (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5587124 0.88 LMNA (0.50) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5587927 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL10608059 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL10705985 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5587993 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5589402 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5587069 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15
SCHEMBL5589305 0.86 LMNA (0.53) LMNAMAPTALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115591005-A Preparation and application of breathable waterproof nano-film dressing based on traditional Chinese medicine antibiosis 成都大学(CN) 2023-01-13 CN claimed
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2021-05-06 US claimed
EP-3661902-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS Universiteit Antwerpen (BE) 2020-06-10 EP claimed
CN-110172303-A A kind of stone adhesive and preparation method thereof 浙江久而久化学有限公司 2019-08-27 CN claimed
WO-2019025535-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2019-02-07 WO claimed
CN-110997884-B Metal working oil composition and method for producing metal sheet laminate 出光兴产株式会社 2023-06-20 CN disclosed
CN-115591005-A Preparation and application of breathable waterproof nano-film dressing based on traditional Chinese medicine antibiosis 成都大学(CN) 2023-01-13 CN disclosed
CN-115591005-A Preparation and application of breathable waterproof nano-film dressing based on traditional Chinese medicine antibiosis 成都大学(CN) 2023-01-13 CN disclosed
CN-110172303-A A kind of stone adhesive and preparation method thereof 浙江久而久化学有限公司 2019-08-27 CN disclosed
EP-2318477-B1 ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES FUJIFILM ELECTRONIC MAT USA INC (US) 2019-06-05 EP disclosed
EP-2709977-B1 USE OF BENZOTROPOLONE DERIVATIVES AS PHOTOSTABILIZER AND ANTIOXIDANT FOR STABILIZATION OF BODY-CARE AND HOUSEHOLD PRODUCTS. BASF SE (DE) 2018-09-05 EP disclosed
US-9663442-B2 Stabilization of household, body-care and food products by using benzotropolone containing plant extracts and/or related benzotropolone derivatives BASF SE (DE) 2017-05-30 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
CN-1156274-C Medicinal ointment containing zinc salt of conjugated linoleic acid and sodium humate 中国科学院新疆理化技术研究所 2004-07-07 CN disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed
CN-1372926-A Medicinal ointment containing zinc salt of conjugated linoleic acid and sodium humate XINJIANG INST CHEMISTRY CAS (CN) 2002-10-09 CN disclosed
CN-1252714-A Preventives for reconstriction TAISHO PHARMACEUTICAL CO LTD (JP) 2000-05-10 CN disclosed
CN-1252715-A Preventives for ischemic heart diseases TAISHO PHARMACEUTICAL CO LTD (JP) 2000-05-10 CN disclosed
EP-0983763-A1 PREVENTIVES FOR RECONSTRICTION TAISHO PHARMACEUTICAL CO., LTD (JP) 2000-03-08 EP disclosed
EP-0983764-A1 PREVENTIVES FOR ISCHEMIC HEART DISEASES TAISHO PHARMACEUTICAL CO., LTD (JP) 2000-03-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS HAAO, TDO2, HPD LMNA 4001/4885MAPT 3337/4885ALDH1A1 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.